Sůla K, Nouza K, Madar J, Cihák A
Institute of Experimental Medicine, Czechoslovak Academy of Sciences, Prague.
Czech Med. 1987;10(2):99-108.
5-azacytidine [5-AzCR] and 5-aza-2'-deoxycytidine [5-AzCdR] can produce an immunosuppressive or an immunostimulatory effect on the graft-versus-host or host-versus-graft reactions in the regional popliteal lymph node of the mouse. The result depends on the dose of the drug and the time between its administration and induction of the cell-mediated immune response. Syngeneic spleen cells are capable of inducing regional lymphadenomegaly if injected into the footpads of recipients treated 1 day previously or concurrently with 5-AzCR or 5-AzCdR. Spleen cells from allogeneic and syngeneic donors treated with 5-AzCR or 5-AzCdR in vivo or in vitro can elicit greater regional lymphadenomegaly than the untreated cells. Both drugs not only seem to influence the proliferative activity of effector and regulatory populations of immunocompetent cells, but they probably also change their recognition ability and immunogenic properties.
5-氮杂胞苷[5-AzCR]和5-氮杂-2'-脱氧胞苷[5-AzCdR]可对小鼠腘窝局部淋巴结中的移植物抗宿主或宿主抗移植物反应产生免疫抑制或免疫刺激作用。结果取决于药物剂量及其给药与细胞介导免疫反应诱导之间的时间间隔。如果将同基因脾细胞注射到1天前或与5-AzCR或5-AzCdR同时处理的受体的足垫中,它们能够诱导局部淋巴结肿大。在体内或体外经5-AzCR或5-AzCdR处理的同种异体和同基因供体的脾细胞,比未处理的细胞能引起更大的局部淋巴结肿大。这两种药物似乎不仅影响免疫活性细胞效应群体和调节群体的增殖活性,而且可能还会改变它们的识别能力和免疫原性。